Eva Dawin
Muenster, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
HLA-A∗03:01 as predictive genetic biomarker for glatiramer acetate treatment response in multiple sclerosis: a retrospective cohort analysis.
Journal: EBioMedicine
Published: May 30, 2025
Worse recovery from acute attacks and faster disability accumulation highlights the unmet need for improved treatment in patients with late-onset neuromyelitis optica spectrum disorders (COPTER-LO study).
Journal: Frontiers in immunology
Published: February 12, 2025
Real-world multicentre cohort study on choices and effectiveness of immunotherapies in NMOSD and MOGAD.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: August 02, 2024
Visual quality of life in NMOSD and MOGAD: profiles, dynamics and associations with ageing and vision.
Journal: Journal of neurology
Published: July 08, 2024
Multiple sclerosis endophenotypes identified by high-dimensional blood signatures are associated with distinct disease trajectories.
Journal: Science translational medicine
Published: March 27, 2024
Broader anti-EBV TCR repertoire in multiple sclerosis: disease specificity and treatment modulation.
Broader anti-EBV TCR repertoire in multiple sclerosis: disease specificity and treatment modulation.
Journal: Brain : a journal of neurology
Published: January 30, 2024
Time to Disability Milestones and Annualized Relapse Rates in NMOSD and MOGAD.
Journal: Annals of neurology
Published: September 08, 2023
LUBAC assembles a ubiquitin signaling platform at mitochondria for signal amplification and transport of NF-κB to the nucleus.
Journal: The EMBO journal
Published: June 29, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026